Publicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (63)

2024

  1. Antibiotic stewardship programs in the Spanish emergency services: PROA-URG Study

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 163-169

2023

  1. Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia

    Farmacia Hospitalaria, Vol. 47, Núm. 3, pp. 100-105

  2. Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1

    Journal of medical economics, Vol. 26, Núm. 1, pp. 445-453

  3. Drug-related problems as reason for emergency department visit: 3 years of the FARM-URG registry

    International Journal of Pharmacy Practice, Vol. 31, Núm. 4, pp. 417-422

  4. Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain

    BMC Pulmonary Medicine, Vol. 23, Núm. 1

  5. Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2291-2296

  6. Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 430-435

2022

  1. Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain

    Farmacia Hospitalaria, Vol. 46, Núm. 6, pp. 327-334

  2. Análisis coste-utilidad de venetoclax en combinación con obinutuzumab como tratamiento de primera línea de la leucemia linfocítica crónica en España

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 3, pp. 121-132

  3. Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines

    Clinical and Translational Oncology, Vol. 24, Núm. 3, pp. 483-494

  4. Location, morphology and invasiveness of lateral spreading tumors in the colorectum differ between two large cohorts from an eastern and western country

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 6, pp. 440-449

  5. Protocolo de validación de la herramienta de desprescripción LESS-CHRON en pacientes pluripatológicos. Proyecto LESS-CHRON-VALIDATION

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 5, pp. 311-315

  6. Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC

    Cancers, Vol. 14, Núm. 9

  7. Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies

    Archivos de Bronconeumologia

2021

  1. Evaluation of the potential of total proanthocyanidin content in feces as an intake biomarker

    Food Research International, Vol. 145

  2. Gestión del proceso posanalítico en los laboratorios clínicos según los requisitos de la norma ISO 15189:2012. Consideraciones sobre la revisión, notificación y comunicación de los resultados

    Advances in Laboratory Medicine, Vol. 2, Núm. 1, pp. 61-70

  3. Management of post-Analytical processes in the clinical laboratory according to ISO 15189:2012. Considerations about the management of clinical samples, ensuring quality of post-Analytical processes, and laboratory information management

    Advances in Laboratory Medicine, Vol. 2, Núm. 3, pp. 373-380

  4. Management of postanalytical processes in the clinical laboratory according to ISO 15189:2012 Standard requirements: Considerations on the review, reporting and release of results

    Advances in Laboratory Medicine, Vol. 2, Núm. 1, pp. 51-59

  5. Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women

    Viruses, Vol. 13, Núm. 1

  6. The Answer to "When to Clip" After Colorectal Endoscopic Mucosal Resection Based on a Cost-Effectiveness Analysis

    The American journal of gastroenterology, Vol. 116, Núm. 2, pp. 311-318